The never ending controversy...
RT @CJA_Journal: Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @sa…
Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @salkanji @OttawaHospital @CritCareSociety https://t.co/xOD9Fk19sX
RT @CJA_Journal: Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @sa…
RT @CJA_Journal: Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @sa…
RT @CJA_Journal: Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @sa…
Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @salkanji @OttawaHospital @CritCareSociety #CriticalCare #ANES18 https://t.co/bcLGxM6es5
Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome https://t.co/vUgBMhGAw8 from @salkanji @OttawaHospital @CritCareSociety #CriticalCare #CJA https://t.co/SKZeWPRYFA
Use of a sustained-release T3 product may improve clinical outcome in critically ill patients https://t.co/Jc3vX6jotv
#AFib Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome. https://t.co/hvchHIJ0GN
Wondering about the safety of oral T3 in the treatment of sick euthyroid syndrome (non-thyroidal illness syndrome)? Hot off the press. https://t.co/38FKcxgaeW #ICU #cytomel #criticalcare